Antibodies to certain antigens have been found to be useful markers of SCLC, most notably SOXB1 group antigens (SOX1, SOX2, SOX3), Sry-like high mobility group box proteins that are expressed in neuronal precursor cells and adult human cerebellum (Alcock et al., 2009). The gene discussed is SOX1; the disease is small cell lung carcinoma.